Artigos com autorizações de acesso público - vincenzo solfrizziSaiba mais
Não disponíveis em nenhum local: 12
Rever
Age-related hearing impairment—a risk factor and frailty marker for dementia and AD
F Panza, V Solfrizzi, G Logroscino
Nature Reviews Neurology 11 (3), 166-175, 2015
Autorizações: Government of Italy
Rever
Cognitive frailty: a systematic review of epidemiological and neurobiological evidence of an age-related clinical condition
F Panza, V Solfrizzi, MR Barulli, A Santamato, D Seripa, A Pilotto, ...
Rejuvenation research 18 (5), 389-412, 2015
Autorizações: Government of Italy
Rever
Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?
F Panza, G Logroscino, BP Imbimbo, V Solfrizzi
Current opinion in psychiatry 27 (2), 128-137, 2014
Autorizações: Government of Italy
Rever
Amyloid-directed monoclonal antibodies for the treatment of Alzheimer’s disease: the point of no return?
F Panza, V Solfrizzi, BP Imbimbo, G Logroscino
Expert opinion on biological therapy 14 (10), 1465-1476, 2014
Autorizações: Government of Italy
Rever
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients
F Panza, D Seripa, V Solfrizzi, BP Imbimbo, M Lozupone, A Leo, ...
Expert opinion on emerging drugs 21 (4), 377-391, 2016
Autorizações: Government of Italy
Rever
Nutritional domains in frailty tools: Working towards an operational definition of nutritional frailty
R Zupo, F Castellana, I Bortone, C Griseta, R Sardone, L Lampignano, ...
Ageing research reviews 64, 101148, 2020
Autorizações: US National Institutes of Health, Government of Italy
Rever
Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium
D Seripa, V Solfrizzi, BP Imbimbo, A Daniele, A Santamato, M Lozupone, ...
Expert Review of Neurotherapeutics 16 (3), 259-277, 2016
Autorizações: Government of Italy
Rever
The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset
F Panza, D Seripa, M Lozupone, V Solfrizzi, BP Imbimbo, MR Barulli, ...
Expert opinion on biological therapy 18 (1), 25-35, 2018
Autorizações: Government of Italy
Rever
Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?
M Lozupone, BP Imbimbo, C Balducci, F Lo Vecchio, P Bisceglia, ...
Alzheimer's & Dementia 19 (1), 353-368, 2023
Autorizações: Government of Italy
Rever
Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathies
F Panza, V Dibello, R Sardone, F Castellana, R Zupo, L Lampignano, ...
Expert Opinion on Investigational Drugs 32 (7), 625-634, 2023
Autorizações: Government of Italy
Rever
Mediterranean dietary pattern, mild cognitive impairment, and progression to dementia
V Solfrizzi, V Frisardi, C Capurso, A D’Introno, AM Colacicco, ...
Archives of neurology 66 (7), 910-916, 2009
Autorizações: US National Institutes of Health
Rever
Late-onset depression but not early-onset depression may increase the risk of all-cause mortality in older age: 8-year follow-up of the Salus in Apulia Study
M Lozupone, F Castellana, R Sardone, G Berardino, A Mollica, R Zupo, ...
Journal of the American Medical Directors Association 24 (5), 679-687, 2023
Autorizações: US National Institutes of Health, Government of Italy
Disponíveis em algum local: 73
Rever
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128· 9 million …
L Abarca-Gómez, ZA Abdeen, ZA Hamid, NM Abu-Rmeileh, ...
The lancet 390 (10113), 2627-2642, 2017
Autorizações: US National Institutes of Health, British Heart Foundation, Cancer Research …
Rever
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19· 2 million participants
NCD Risk Factor Collaboration
Lancet (London, England) 387 (10026), 1377, 2016
Autorizações: British Heart Foundation, UK Economic and Social Research Council, UK …
Rever
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4· 4 million participants
B Zhou, Y Lu, K Hajifathalian, J Bentham, M Di Cesare, G Danaei, H Bixby, ...
The lancet 387 (10027), 1513-1530, 2016
Autorizações: British Heart Foundation, UK Medical Research Council, National Institute …
Rever
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19· 1 million participants
B Zhou, J Bentham, M Di Cesare, H Bixby, G Danaei, MJ Cowan, ...
The Lancet 389 (10064), 37-55, 2017
Autorizações: US National Institutes of Health, British Heart Foundation, UK Economic and …
Rever
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
JC Lambert, S Heath, G Even, D Campion, K Sleegers, M Hiltunen, ...
Nature genetics 41 (10), 1094-1099, 2009
Autorizações: Research Foundation (Flanders), National Institute of Health and Medical …
Rever
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 …
B Zhou, RM Carrillo-Larco, G Danaei, LM Riley, CJ Paciorek, GA Stevens, ...
The lancet 398 (10304), 957-980, 2021
Autorizações: US National Institutes of Health, British Heart Foundation, UK Medical …
Rever
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
Autorizações: US National Institutes of Health, Motor Neurone Disease Association, UK, UK …
Rever
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
P Hollingworth, D Harold, R Sims, A Gerrish, JC Lambert, ...
Nature genetics 43 (5), 429-435, 2011
Autorizações: US National Institutes of Health, Research Foundation (Flanders), National …
As informações de publicação e financiamento são determinadas automaticamente por um programa informático.